This year, Axsome Therapeutics (NASDAQ:AXSM) will be filing a New Drug Application for a novel therapy to treat depression. For millions of adults with depression worldwide, the drug candidate may rapidly replace traditional standards of care.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,